GB0600916D0 - detecting and predicting pre-eclampsia - Google Patents

detecting and predicting pre-eclampsia

Info

Publication number
GB0600916D0
GB0600916D0 GBGB0600916.1A GB0600916A GB0600916D0 GB 0600916 D0 GB0600916 D0 GB 0600916D0 GB 0600916 A GB0600916 A GB 0600916A GB 0600916 D0 GB0600916 D0 GB 0600916D0
Authority
GB
United Kingdom
Prior art keywords
eclampsia
detecting
predicting
predicting pre
technology described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0600916.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revvity Health Sciences Inc
Original Assignee
PerkinElmer LAS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PerkinElmer LAS Inc filed Critical PerkinElmer LAS Inc
Priority to GBGB0600916.1A priority Critical patent/GB0600916D0/en
Publication of GB0600916D0 publication Critical patent/GB0600916D0/en
Priority to US11/623,480 priority patent/US7638287B2/en
Priority to JP2008549934A priority patent/JP2009524014A/ja
Priority to ES07700392T priority patent/ES2364314T3/es
Priority to CA2602681A priority patent/CA2602681C/en
Priority to PCT/GB2007/000123 priority patent/WO2007083099A1/en
Priority to EP07700392A priority patent/EP1974220B1/en
Priority to DE602007013524T priority patent/DE602007013524D1/de
Priority to HK08112797.2A priority patent/HK1119244B/en
Priority to AU2007206756A priority patent/AU2007206756B2/en
Priority to AT07700392T priority patent/ATE504002T1/de
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Mold Materials And Core Materials (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Holo Graphy (AREA)
GBGB0600916.1A 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia Ceased GB0600916D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia
US11/623,480 US7638287B2 (en) 2006-01-17 2007-01-16 Detecting and predicting pre-eclampsia
AT07700392T ATE504002T1 (de) 2006-01-17 2007-01-17 Erkennung und vorhersage von frühgeburten
CA2602681A CA2602681C (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia
ES07700392T ES2364314T3 (es) 2006-01-17 2007-01-17 Detección y predicción de preeclampsia.
JP2008549934A JP2009524014A (ja) 2006-01-17 2007-01-17 子癇前症の検出及び予測
PCT/GB2007/000123 WO2007083099A1 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia
EP07700392A EP1974220B1 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia
DE602007013524T DE602007013524D1 (de) 2006-01-17 2007-01-17 Erkennung und vorhersage von frühgeburten
HK08112797.2A HK1119244B (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia
AU2007206756A AU2007206756B2 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia

Publications (1)

Publication Number Publication Date
GB0600916D0 true GB0600916D0 (en) 2006-02-22

Family

ID=35998177

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0600916.1A Ceased GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia

Country Status (10)

Country Link
US (1) US7638287B2 (cg-RX-API-DMAC7.html)
EP (1) EP1974220B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009524014A (cg-RX-API-DMAC7.html)
AT (1) ATE504002T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007206756B2 (cg-RX-API-DMAC7.html)
CA (1) CA2602681C (cg-RX-API-DMAC7.html)
DE (1) DE602007013524D1 (cg-RX-API-DMAC7.html)
ES (1) ES2364314T3 (cg-RX-API-DMAC7.html)
GB (1) GB0600916D0 (cg-RX-API-DMAC7.html)
WO (1) WO2007083099A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA022609B1 (ru) 2007-02-12 2016-02-29 А1М Фарма Аб Применение свободного фетального гемоглобина в качестве маркера преэклампсии
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
WO2009094665A1 (en) * 2008-01-25 2009-07-30 Perkinelmer Health Sciences, Inc. Methods for determining the risk of prenatal complications
US20110294227A1 (en) * 2008-11-20 2011-12-01 Perkinelmer Health Sciences, Inc. Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
HRP20150802T1 (xx) * 2010-03-24 2015-11-06 Preelumina Diagnostics Ab Hbf i a1m kao markeri za rano otkrivanje preeklampsije
AU2012351504C1 (en) * 2011-12-15 2018-04-26 Mycartis N.V. Biomarkers and parameters for preeclampsia
US20150157276A1 (en) * 2012-04-24 2015-06-11 Siemens Healthcare Diagnostics Inc. Pre-eclampsia screening methods
EP2954324B1 (en) * 2013-02-08 2019-07-31 University of Iowa Research Foundation Method using copeptin to predict onset of preeclampsia
US10119978B2 (en) 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
PL3189336T3 (pl) 2014-09-02 2019-07-31 Wallac Oy Sposób określania ryzyka stanu przedrzucawkowego
FR3037657B1 (fr) * 2015-06-22 2017-06-23 Univ Rouen Centre Hospitalier Methode de diagnostic des troubles causes par l'alcoolisation foetale
WO2019099998A1 (en) * 2017-11-17 2019-05-23 University Of Washington Connected system for information-enhanced test results
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECLAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR TESTS
WO2022173786A1 (en) * 2021-02-10 2022-08-18 Mirvie, Inc. Methods and systems for conducting pregnancy-related clinical trials
FR3157091A1 (fr) * 2023-12-26 2025-06-27 Universite De Montpellier Prédiction du comportement biomécanique de la paroi artérielle à travers l’analyse temporelle du signal oscillométrique au cours de la mesure de pression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998028006A1 (en) 1996-12-23 1998-07-02 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
GB0026823D0 (en) 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
ES2556164T3 (es) * 2003-09-23 2016-01-13 The General Hospital Corporation Cribado de la preeclampsia
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor

Also Published As

Publication number Publication date
AU2007206756A1 (en) 2007-07-26
CA2602681C (en) 2017-03-14
CA2602681A1 (en) 2007-07-26
US7638287B2 (en) 2009-12-29
EP1974220A1 (en) 2008-10-01
EP1974220B1 (en) 2011-03-30
ES2364314T3 (es) 2011-08-31
JP2009524014A (ja) 2009-06-25
DE602007013524D1 (de) 2011-05-12
HK1119244A1 (en) 2009-02-27
ES2364314T8 (es) 2011-09-22
AU2007206756B2 (en) 2011-06-16
ATE504002T1 (de) 2011-04-15
WO2007083099A1 (en) 2007-07-26
US20070178530A1 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
ES2364314T8 (es) Detección y predicción de preeclampsia.
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
EP2114241A4 (en) METHOD AND SYSTEM FOR PROVIDING ANALYTE MONITORING
WO2009048530A3 (en) Highly multiplexed particle-based assays
WO2010129934A3 (en) Methods and compositions for diagnosis of thyroid conditions
WO2007100506A3 (en) Mass tags for quantitative analyses
WO2008024473A3 (en) Mapping of genomic interactions
WO2008005321A3 (en) Systems and methods for real-time pcr
WO2010019414A3 (en) Detecting nucleic acid
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2009105212A3 (en) Detection of polyomavirus
WO2012037937A3 (de) Verfahren zum nachweis, differenzieren und quantifizieren von t-zellpopulationen mittels der reverse transkription quantitativen real-time pcr (rt-qpcr) technologie
WO2010075360A3 (en) Methods for detection of sepsis
EP2011868A4 (en) MODIFIED CREATININAMIDE HYDROLASE WITH IMPROVED SUBSTRATEFFINITY AND REAGENT COMPOSITION FOR THE DETERMINATION OF CREATININE
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
WO2011142781A3 (en) Pore-limit electrophoresis (ple) microchannel assays
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
MX2009004852A (es) Procedimiento para la determinacion de la fragmentacion del adn en microorganismos.
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
WO2009092982A3 (fr) Procédé de détection et/ou d'identification de clostridium difficile

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)